Cargando…
Exploiting metabolic vulnerabilities in breast cancers with NF1 loss
Auf der Maur et al.(1) identify neurofibromin 1 (NF1) loss as a mechanism of resistance to PI3K inhibitor in breast cancer cells. NF1 loss leads to enhanced glycolysis, which may be targeted with the antioxidant N-acetyl cysteine (NAC).
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140605/ https://www.ncbi.nlm.nih.gov/pubmed/37075699 http://dx.doi.org/10.1016/j.xcrm.2023.101010 |
_version_ | 1785033199430139904 |
---|---|
author | Yap, Yoon-Sim Hu, Jiancheng |
author_facet | Yap, Yoon-Sim Hu, Jiancheng |
author_sort | Yap, Yoon-Sim |
collection | PubMed |
description | Auf der Maur et al.(1) identify neurofibromin 1 (NF1) loss as a mechanism of resistance to PI3K inhibitor in breast cancer cells. NF1 loss leads to enhanced glycolysis, which may be targeted with the antioxidant N-acetyl cysteine (NAC). |
format | Online Article Text |
id | pubmed-10140605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-101406052023-04-29 Exploiting metabolic vulnerabilities in breast cancers with NF1 loss Yap, Yoon-Sim Hu, Jiancheng Cell Rep Med Preview Auf der Maur et al.(1) identify neurofibromin 1 (NF1) loss as a mechanism of resistance to PI3K inhibitor in breast cancer cells. NF1 loss leads to enhanced glycolysis, which may be targeted with the antioxidant N-acetyl cysteine (NAC). Elsevier 2023-04-18 /pmc/articles/PMC10140605/ /pubmed/37075699 http://dx.doi.org/10.1016/j.xcrm.2023.101010 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Preview Yap, Yoon-Sim Hu, Jiancheng Exploiting metabolic vulnerabilities in breast cancers with NF1 loss |
title | Exploiting metabolic vulnerabilities in breast cancers with NF1 loss |
title_full | Exploiting metabolic vulnerabilities in breast cancers with NF1 loss |
title_fullStr | Exploiting metabolic vulnerabilities in breast cancers with NF1 loss |
title_full_unstemmed | Exploiting metabolic vulnerabilities in breast cancers with NF1 loss |
title_short | Exploiting metabolic vulnerabilities in breast cancers with NF1 loss |
title_sort | exploiting metabolic vulnerabilities in breast cancers with nf1 loss |
topic | Preview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140605/ https://www.ncbi.nlm.nih.gov/pubmed/37075699 http://dx.doi.org/10.1016/j.xcrm.2023.101010 |
work_keys_str_mv | AT yapyoonsim exploitingmetabolicvulnerabilitiesinbreastcancerswithnf1loss AT hujiancheng exploitingmetabolicvulnerabilitiesinbreastcancerswithnf1loss |